1 Min Read
May 19 (Reuters) - HANSA MEDICAL AB:
* PRIME DESIGNATION FOR IDES WAS GRANTED ON BASIS OF DATA FROM FOUR INDEPENDENT PHASE II STUDIES IN U.S. AND SWEDEN Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.